39
Views
0
CrossRef citations to date
0
Altmetric
Pesticide Chemistry

MT-5950, a New Anilide Herbicide, Inhibits PSII at a Site that Slightly Overlaps the Triazine Binding Site

, &
Pages 465-472 | Received 26 Aug 1987, Published online: 06 Jun 2016
 

Abstract

The new selective acylanilide herbicide, MT-5950 [N-(3-chloro-4-isopropylphenyl)-2- methylpentanamide], was found to be a potent inhibitor of photosystem II (PS II) in photosynthesis. It was not as effective as atrazine in increasing variable fluorescence of wheat leaves dipped in herbicide solutions. However, in assays in which absorption across the leaf cuticle did not play a role, MT-5950 was about 10-fold more effective than atrazine in inhibiting the PSII activity of all the species tested. For example, the I50 values of MT-5950 and atrazine for inhibiting linear electron transport in broken chloroplasts of spinach were 0.08 and 0.8 μm, respectively. Atrazine- resistant biotypes of Brassica napus and Solanum nigrum were about 10-fold and < 2-fold less susceptible, respectively, to MT-5950 than were susceptible biotypes of the same species as measured by DCPIP photoreduction and CO2-dependent oxygen evolution. However, MT-5950 was equally as effective as atrazine in competing for 14C-labeled atrazine from thylakoid proteins. We conclude that MT-5950 inhibits PS II by binding the quinone-binding 32 kD protein at a site that overlaps the binding site of atrazine, but does not significantly overlap that portion of the atrazine binding site that, when modified, confers atrazine resistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.